Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Neurocognitive Deficits in Childhood Cancer Survivors
NCT01700959Phase 3Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Feb 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in neurocognitive disorder (NCD), sponsored by St. Jude Children's Research Hospital. Started Feb 2013; status: completed.
02
Drugs
melatonin
03
Conditions
neurocognitive disorder (NCD)
Beyond the preview
Go deeper on NCT01700959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01700959.